Publications
Detailed Information
Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Soie | - |
dc.contributor.author | Kim, Ji-Eun | - |
dc.contributor.author | Lee, Dong Soon | - |
dc.contributor.author | Kim, Ju Young | - |
dc.contributor.author | Han, Kyou-Sup | - |
dc.contributor.author | Kim, Hyun Kyung | - |
dc.date.accessioned | 2012-05-23T02:05:09Z | - |
dc.date.available | 2012-05-23T02:05:09Z | - |
dc.date.issued | 2010-06 | - |
dc.identifier.citation | THROMBOSIS RESEARCH; Vol.125 6; E285-E293 | ko_KR |
dc.identifier.issn | 0049-3848 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76307 | - |
dc.description.abstract | Background: Hepatocyte growth factor (HGF), a pleiotropic factor regulating development and wound healing, is secreted as inactive pro-HGF and is converted into active HGF by coagulation serine proteases. HGF receptor overexpression can cause massive venous thrombi, and factor Xa is reported to release soluble HGF from granulocytes. We hypothesized that a hypercoagulable condition, such as disseminated intravascular coagulation (DIC), may increase circulating HGF through active cleavage by coagulation serine proteases. Methods: In 172 DIC-suspected patients, plasma levels of total and active HGF, thrombin-antithrombin complex (TAT), plasmin-antiplasmin complex (PAP), and interleukin (IL)-6 were measured by ELISA. Active HGF release in granulocytes was examined in patients with and without overt-DIC. HGF-induced tissue factor expression in peripheral monocytes was measured by flow cytometry. Results: Circulating levels of total and active HGF correlated well with coagulopathy severity, including DIC score, D-dimer, TAT and PAP levels. HGF positively correlated with IL-6 and absolute neutrophil count. In contrast to the cancer group, HGF levels were significantly increased in accordance with increased DIC scores in non-cancer group. Elevated circulating HGF was an independent prognostic marker in the non-cancer group, while HGF level failed to predict mortality in the cancer group. Amounts of HGF released from stimulated granulocytes were not significantly different between overt-DIC and no overt-DIC patients. HGF potentiated endotoxin-induced tissue factor expression of monocytes in vitro. Conclusion: These findings suggest that circulating HGF is a potential laboratory marker reflecting coagulation activity and DIC prognosis in non-cancer patients and that HGF may play a role in a vicious cycle of hypercoagulability. (C) 2010 Elsevier Ltd. All rights reserved. | ko_KR |
dc.description.sponsorship | This study was supported by a grant of the Korea Healthcare
Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A080720), by a National Research Foundation of Korea Grant funded by the Korean Government (2009-0075731) and by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-2008-331-E00312). | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | ko_KR |
dc.title | Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 정소이 | - |
dc.contributor.AlternativeAuthor | 이동순 | - |
dc.contributor.AlternativeAuthor | 한규섭 | - |
dc.contributor.AlternativeAuthor | 김현경 | - |
dc.contributor.AlternativeAuthor | 김지은 | - |
dc.contributor.AlternativeAuthor | 김주영 | - |
dc.identifier.doi | 10.1016/j.thromres.2010.01.046 | - |
dc.citation.journaltitle | THROMBOSIS RESEARCH | - |
dc.description.citedreference | Sakon M, 1999, INT J CLIN LAB RES, V29, P110 | - |
dc.description.citedreference | Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209 | - |
dc.description.citedreference | Matsumori A, 1998, JPN CIRC J, V62, P311 | - |
dc.description.citedreference | Toi M, 1998, CLIN CANCER RES, V4, P659 | - |
dc.description.citedreference | SATO T, 1998, J CARDIOL, V32, P77 | - |
dc.description.citedreference | Siegfried JM, 1997, CANCER RES, V57, P433 | - |
dc.description.citedreference | Taniguchi T, 1997, BRIT J CANCER, V75, P673 | - |
dc.description.citedreference | Matsumori A, 1996, BIOCHEM BIOPH RES CO, V221, P391 | - |
dc.description.citedreference | Ueda T, 1996, PANCREAS, V12, P76 | - |
dc.description.citedreference | Gohji K, 2000, J CLIN ONCOL, V18, P2963 | - |
dc.description.citedreference | Naughton M, 2001, J UROLOGY, V165, P1325 | - |
dc.description.citedreference | Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327 | - |
dc.description.citedreference | Nayeri F, 2002, CYTOKINE, V19, P201, DOI 10.1006/cyto.2002.1050 | - |
dc.description.citedreference | Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1 | - |
dc.description.citedreference | Ohnishi T, 2003, ARCH ORAL BIOL, V48, P797, DOI 10.1016/S0003-9969(03)00180-8 | - |
dc.description.citedreference | Matsushima A, 2004, J TRAUMA, V56, P259, DOI 10.1097/01.TA.0000111752.60500.DA | - |
dc.description.citedreference | HASHEM M, 2005, J EGYPT NATL CANC I, V17, P114 | - |
dc.description.citedreference | Boccaccio C, 2005, NATURE, V434, P396, DOI 10.1038/nature03357 | - |
dc.description.citedreference | Khan KN, 2005, HUM REPROD, V20, P2715, DOI 10.1093/humrep/dei156 | - |
dc.description.citedreference | Ohnishi T, 2006, J IMMUNOL, V176, P6945 | - |
dc.description.citedreference | Matsuoka H, 2006, AM J RESP CELL MOL, V35, P705, DOI 10.1165/rcmb.2006-0006OC | - |
dc.description.citedreference | Toh CH, 2007, J THROMB HAEMOST, V5, P604 | - |
dc.description.citedreference | Matsuo R, 2008, J SURG RES, V145, P279, DOI 10.1016/j.jss.2007.02.035 | - |
dc.description.citedreference | Provencal M, 2009, CARCINOGENESIS, V30, P1089, DOI 10.1093/carcin/bgp085 | - |
dc.description.citedreference | Toiyama Y, 2009, INT J CANCER, V125, P1657, DOI 10.1002/ijc.24554 | - |
dc.description.citedreference | MAEDA J, 1995, AM J RESP CRIT CARE, V152, P1587 | - |
dc.description.citedreference | NAKAMURA Y, 1995, BIOCHEM BIOPH RES CO, V215, P483 | - |
dc.description.citedreference | SHIMOMURA T, 1995, EUR J BIOCHEM, V229, P257 | - |
dc.description.citedreference | SHIOTA G, 1995, HEPATOLOGY, V21, P106 | - |
dc.description.citedreference | ROSEN EM, 1994, J CELL BIOL, V127, P1783 | - |
dc.description.citedreference | WOJTA J, 1994, BLOOD, V84, P151 | - |
dc.description.citedreference | RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357 | - |
dc.description.citedreference | APPASAMY R, 1993, LAB INVEST, V68, P270 | - |
dc.description.citedreference | BUSSOLINO F, 1992, J CELL BIOL, V119, P629 | - |
dc.description.citedreference | MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235 | - |
dc.description.citedreference | KONO S, 1992, BIOCHEM BIOPH RES CO, V186, P991 | - |
dc.description.citedreference | YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802 | - |
dc.description.citedreference | NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.